unsupervised, semi-supervised, or reinforcement method to learn from complex disease representation (Table 1) ; the most frequently studied problems in MPS so far have been supervised. Similarly, Alonso et al. trained an assortment of supervised machine learning algorithms to appraise the accuracy and interpretability in contrast to widely popular logistic regression. In a retrospective analysis, the authors extracted a total of 122 clinical and imaging features from 8321 patients (their database previously reported diverse patient groups including those with valvular heart disease and non-ischemic cardiomyopathy, coronary artery bypass grafting and percutaneous coronary intervention) who underwent dual-isotope MPS with adenosine stress test. All machine learning models were evaluated with fivefold cross-validation for optimization to reduce overfitting. The machine learning models outperformed the parametric statistical model in predicting cardiac death. Support vector machine-a popular classification tool known for its accuracy and generalizability-performed the best among the list of algorithms tested. 4 Interestingly, however, lasso regression (least absolute shrinkage and selection operator) modified to shrink parameters performed better with only 6 features than the logistic regression with 14 features.
Do the results of the present study mean that our predilection for statistical methods is fading as we become more reliant on machine learning? Perhaps, not categorically; it depends on the purpose of the analysis. There are overlaps in algorithms and methods in the orbits of both statistical models and machine learning algorithms, but the salient characteristic difference must be realized. Machine learning seeks to learn from the data without specific programming, whereas statistical models formalize the relationship between the variables for inference; they both learn from the data, but the purpose and approaches are different. Every statistical model comes with its own set of assumptions that need to be validated using statistical tools 5 and tactics such as diagnostics, transformation, and model validations to determine the quality of the model. Nevertheless, prediction is not a strong suit of statistics since it makes use of estimation of parameters. This was well illustrated in the present investigation where the machine learning classification algorithm-support vector machine (Area under the curve, AUC: 0.83) outperformed parametric regression model-logistic regression (AUC: 0.76).
Several recent studies in Nuclear Cardiology 7-13 have attempted to use machine learning in the identification of perfusion defects and location, prediction of revascularization and cardiovascular events, and diagnostic and prognostic accuracy ( Table 2 ). However, viewing through the lens of these studies, the investigation by Alonso et al., is singular to apply supervised machine learning in predicting cardiac death from the features while attempting to identify interpretable highperformance model. The investigators additionally demonstrated an enticing visualization tool to risk assessment that is manifested by features' contribution to the risk and patient's ranking with respect to the population. The value of such interpretation scheme would require to be prospectively evaluated in future studies. 14 While training supervised machine learning model, the feature space derived from the perfusion quantification and clinical variables must be supplied in conjunction with the outcomes. The application of supervised machine learning requires intense preparations in collecting, identifying, and classifying the diseases before the data can be utilized. The outcomes of interests however need to be provided with an inherent assumption that features of interest in the data set are somehow related to the outcome. Unsupervised learning, on the other hand, is example agnostic but finds patterns that are otherwise inconceivable. It can distil high-dimensional data from perfusion and functional parameters to comport naturally occurring patterns in the data. It doesn't require a prior label or annotation of the outcome for the dataset, rather it learns and identifies the relations and uncovers the hidden structure. Therefore, exclusively relying in supervised learning methods in heterogeneous datasets may not produce stellar accuracy, inter-observer variability may be introduced, and bias can creep into the algorithm from semi-quantitatively examined MPS data. However, in conjunction with unsupervised learning, it could ameliorate prediction of the localization and severity of hypo-perfusion that accounts to heterogeneity of the patients and the disease. This may be achieved by condensing and representing the data in a low-dimensional space that is rich in features in identifying severity in hypo-perfusion, or by conglomeration of similar patients or features in clustering, for instance.
Deep learning network is another possibility to extract information from heterogenous data and predict cardiac death with very high accuracy, provided there's enough data for it to train with. 15 It learns in increment in each hierarchy of the network layers where it extracts predictive features unlike old generations of machine learning algorithms. It performs by learning from examples rather than engineered and hard-coded features. Interestingly, compared to the performance of shallow machine learning algorithms that plateaus for very large dataset, deep learning is scalable and 16 This could translate to lower-dose exposure to patients during perfusion SPECT, or real-time diagnosis while producing high-quality images. It could augment our current diagnosis processes; and whether it be from perfusion SPECT images or a parametric representation of those images such as polar maps, Fourier decomposition, or segmental uptake, deep learning can be a powerful tool to assist clinicians in reconciling data and build patient-specific treatment decisions while improving report accuracy and turnaround time.
Undoubtedly, there will always be challenges and new opportunities, and our first instinct will always be to understand the clinical implications from new ideas. Some of us may question the viability of novel methods while others may embrace it. Some may question the present study for the value of data provided from a retrospective cohort while nuclear cardiology has advanced over the years through novel instrumentation techniques and cameras, and tracers. 17 While there is little doubt that the generalizability of the model would require external verification in a more contemporary data set, it is imperative we recognize that machine learning is more critical to the evolution of nuclear imaging than we ever imagined. And at the frontier of pioneering technologies and rechristening new methods, one of the most important needs is to develop a set of guidelines and standards for the academic world and industry to evaluate ethical, legal and social implications, and ensure interpretability and reproducibility of the machine learning models. 18, 19 
